|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.35 CNY | +0.07% |
|
-4.57% | -3.01% |
| 07/05 | Sheng Nuo Biotec's Unit Gets Nod to Produce Posaconazole Injection | MT |
| 22/04 | ChengDu ShengNuo Biotec Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
ChengDu ShengNuo Biotec Co.,Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 393.87 million compared to CNY 386.53 million a year ago. Net income was CNY 62.97 million compared to CNY 61.25 million a year ago.
Basic earnings per share from continuing operations was CNY 0.5643 compared to CNY 0.6071 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -3.01% | 424M | |
| +21.63% | 44.11B | |
| +23.03% | 22.71B | |
| +18.22% | 15.15B | |
| +12.66% | 13.56B | |
| +60.18% | 12.7B | |
| -10.02% | 6.84B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +12.92% | 5.63B |
CHENGDU SHENGNUO BIOTEC CO.,LTD. 
